Back to 2014 Annual Meeting Display Posters
Transapical transcatheter aortic valve-in-valve implantation for aortic regurgitation with a self-expandable device in a stentless supra-annular bioprosthesis.
Gry Dahle1, David Holzhey2, Bjørn Bendz1, Jon T. Offstad1, Jan Fredrik Bugge1, Kjell Arne Rein1.
1Rikshospitalet, OUS, Oslo, Norway, 2Heart Center, Leipzig, Leipzig, Germany.
OBJECTIVE: Transcatheter aortic valve implantation (TAVI) has initially been considered as an alternative for high-risk patients with aortic stenosis. Also valve-in-valve (VIV) technique for degenerated bioprostheses is performed for stented as well as for calcified stentless bioprostheses.
With a new generation of self-expandable devices,VIV for aortic regurgitaion (AR) in a stentless bioprosthesis may be an option.
METHODS: A 83 year old woman operated with aortic valve replacement with a stentless supra-annular 25 mm Cryolife O’Brien (CLOB)(Cryolife International, Atlanta,GA) prosthesis ten years ago, was referred. Initial the result of the aortic valve implantation was good, but progressively she developed a severe aortic regurgitation due to degeneration of the prosthesis. VIV was considered and CT measurements were done to evaluate the size of the valve and the implantation angle.A major concern was the short distance between the bioprosthesis and the coronary ostia.
RESULTS: Via a mini left thoracotomy and transapical access, a self-expandable 26 mm Engager™ (Medtronic Inc, Minneapolis, MN) with control arms was implanted in good position. The peroperative angiography showed contrast in both coronary arteries. There were only trace of paravalvular leak (PVL) intraoperativly that ceased upon the echo control two days later. The patient was extubated in the operation room and mobilzed the following day.
CONCLUSIONS: This case report demostrate the feasibility of transapical transcatheter aortic VIV implantation of the Engager™ valve in a degenerated stentless supra-annular CLOB bioprosthesis with aortic regurgitation. This may expand the use of the VIV implantation technique, applicable also in a situation with pure AR.
Back to 2014 Annual Meeting Display Posters

